Som Datt Finance Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve To consider and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Crescentis Capital Ltd has called a Board meeting on Friday, 13 February 2026. The main agenda is to consider and approve the unaudited financial results for the quarter and nine months ended 31 December 2025 (Q3 FY26). The Board will also consider and approve the terms and conditions of the CCL ESOS 2025, an Employee Stock Option Scheme, as recommended by the Nomination and Remuneration Committee. The insider trading window has been closed since 1 January 2026 and will reopen 48 hours after the results are announced. The filing is a standard regulatory disclosure under SEBI Listing Regulations 29 and 33.
This is a routine pre-results intimation with no immediate price impact, but investors should watch for the Q3 numbers on 13 February. If the ESOS 2025 is approved, it could lead to future dilution of existing shareholders depending on the size of the scheme.